Hercules Capital Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| NOVN | Novartis | Hold |
10
|
CHF92.62 | CHF105.00 | 16.20% | 9 | CHF188.98B |
| SAN | Sanofi | Outperform |
16
|
90.24€ | 102.80€ | 21.34% | 9 | 112.81€B |
| BMY | Bristol-Myers Squibb | Hold |
2
|
$44.11 | $58.15 | 22.42% | 10 | $89.42B |
| MRK | Merck KGaA | Outperform |
18
|
168.70€ | 190.06€ | 5.51% | 4 | 73.35€B |
| BIIB | Biogen | Outperform |
10
|
$230.04 | $299.62 | 25.41% | 13 | $33.49B |
| BAYN | Bayer | Hold |
5
|
28.65€ | 45.15€ | 4.71% | 4 | 28.15€B |
| GMAB | Genmab A/S | Outperform |
16
|
kr2.03k | kr2.71k | 30.31% | 14 | kr130.86B |
| TEVA | Teva Pharmaceutical Industries | Outperform |
12
|
$16.30 | $11.59 | 4.29% | 9 | $18.46B |
| ARCC | Ares Capital | Outperform |
14
|
$21.15 | $21.50 | 4.02% | 14 | $12.71B |
| FSK | FS KKR Capital | Hold |
13
|
$19.94 | $21.55 | 0.30% | 10 | $5.56B |
| MAIN | Main Street Capital | Hold |
12
|
$48.65 | $44.17 | 0.72% | 6 | $4.31B |
| ALKS | Alkermes | Outperform |
10
|
$24.46 | $33.27 | 30.83% | 3 | $4.11B |
| GBDC | Golub Capital BDC | Outperform |
14
|
$16.43 | $15.90 | 3.47% | 5 | $2.82B |
| PSEC | Prospect Capital | Underperform |
12
|
$5.61 | $5.50 | -1.96% | 0 | $2.16B |
| TSLX | Sixth Street Specialty Lending | Outperform |
14
|
$21.30 | $21.91 | 5.63% | 10 | $2.00B |
| GSBD | Goldman Sachs BDC | Hold |
12
|
$15.45 | $14.50 | -2.91% | 5 | $1.76B |
| OCSL | Oaktree Specialty Lending Corp | Outperform |
14
|
$19.38 | $7.79 | 3.20% | 6 | $1.51B |
| NMFC | New Mountain Finance | Outperform |
14
|
$12.58 | $13.14 | 3.34% | 6 | $1.35B |
| CSWC | Capital Southwest | Outperform |
15
|
$25.99 | $22.81 | 0.04% | 6 | $1.17B |
| BBDC | Barings BDC | Outperform |
16
|
$9.82 | $9.86 | 4.38% | 6 | $1.02B |
| MFIC | MidCap Financial Investment | Outperform |
13
|
$15.52 | $13.86 | -1.74% | 7 | $1.00B |
| TCPC | BlackRock TCP Capital | Hold |
14
|
$10.83 | $12.50 | -5.36% | 6 | $891.86M |
| CGBD | Carlyle Secured Lending | Hold |
14
|
$17.56 | $15.42 | -3.19% | 6 | $884.85M |
| SLRC | SLR Investment | Hold |
12
|
$16.16 | $15.50 | -0.99% | 9 | $852.14M |
| PFLT | PennantPark Floating Rate Capi... | Hold |
12
|
$11.26 | $11.60 | 2.13% | 4 | $714.27M |
| FDUS | Fidus Investment | Outperform |
14
|
$19.79 | $20.92 | 6.11% | 6 | $621.82M |
| GAIN | Gladstone Investment | Hold |
14
|
$14.19 | $14.60 | -1.34% | 5 | $508.20M |
| GLAD | Gladstone Capital | Hold |
12
|
$22.08 | $10.50 | -0.36% | 4 | $473.59M |
| PNNT | PennantPark Investment | Hold |
13
|
$7.30 | $7.09 | -4.11% | 5 | $471.57M |
| HRZN | Horizon Technology Finance | Hold |
12
|
$11.57 | $11.59 | -13.57% | 7 | $400.99M |
| TPVG | TriplePoint Venture Growth BDC | Hold |
12
|
$9.16 | $10.66 | 3.71% | 8 | $353.25M |
| SCM | Stellus Capital Investment | Hold |
14
|
$14.22 | $14.08 | -1.55% | 5 | $339.21M |
| SAR | Saratoga Investment | Outperform |
4
|
$23.37 | $27.61 | 6.97% | 4 | $323.72M |
| NEWT | NewtekOne | Hold |
16
|
$14.02 | $15.63 | -7.28% | 2 | $284.07M |
| BKCC | BlackRock Capital Investment | - |
12
|
$3.80 | $3.50 | -100.00% | 2 | $275.77M |
| OXSQ | Oxford Square Capital | Hold |
13
|
$3.16 | $4.75 | -38.92% | 0 | $191.55M |
| PTMN | Portman Ridge Finance | Outperform |
13
|
$20.31 | $21.50 | -1.53% | 2 | $180.93M |
| MFIN | Medallion Financial | Outperform |
11
|
$8.00 | $11.00 | 50.00% | 0 | $164.73M |
| MRCC | Monroe Capital | Hold |
14
|
$7.42 | $8.67 | 21.29% | 5 | $156.86M |
| OFS | OFS Capital | Hold |
16
|
$9.87 | $10.75 | -8.81% | 2 | $129.29M |
| PFX | PhenixFIN | Hold |
8
|
$45.50 | $35.00 | -100.00% | 0 | $89.37M |
| LRFC | Logan Ridge Finance | Buy |
10
|
$22.48 | $27.00 | 11.21% | 1 | $58.93M |
| TURN | 180 Degree Capital | - |
-3
|
$4.06 | $12.00 | -100.00% | 0 | $38.50M |